-
1
-
-
0029994543
-
Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression
-
Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 1996; 37:907-925.
-
(1996)
J Lipid Res
, vol.37
, pp. 907-925
-
-
Schoonjans, K.1
Staels, B.2
Auwerx, J.3
-
2
-
-
0030794057
-
Peroxisome proliferates activated receptors, orphans with ligands and functions
-
Schoonjans K, Martin G, Staels B, Auwerx J. Peroxisome proliferates activated receptors, orphans with ligands and functions. Curr Opin Lipidol 1997; 8:159-166.
-
(1997)
Curr Opin Lipidol
, vol.8
, pp. 159-166
-
-
Schoonjans, K.1
Martin, G.2
Staels, B.3
Auwerx, J.4
-
3
-
-
0030952937
-
Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
-
Forman BM, Chen J, Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc Natl Acad Sci USA 1997; 94:4312-4317.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 4312-4317
-
-
Forman, B.M.1
Chen, J.2
Evans, R.M.3
-
4
-
-
0029016829
-
An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ)
-
Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J Biol Chem 1995; 270:12953-12956.
-
(1995)
J Biol Chem
, vol.270
, pp. 12953-12956
-
-
Lehmann, J.M.1
Moore, L.B.2
Smith-Oliver, T.A.3
Wilkison, W.O.4
Willson, T.M.5
Kliewer, S.A.6
-
5
-
-
0029745382
-
Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-γ: Binding and activation correlate with antidiabetic actions in, db/db mice
-
Berger J, Bailey P, Biswas C, Cullinan CA, Doebber TW, Hayes NS, et al. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-γ: binding and activation correlate with antidiabetic actions in, db/db mice. Endocrinology 1996; 137:4189-4195.
-
(1996)
Endocrinology
, vol.137
, pp. 4189-4195
-
-
Berger, J.1
Bailey, P.2
Biswas, C.3
Cullinan, C.A.4
Doebber, T.W.5
Hayes, N.S.6
-
7
-
-
0033049772
-
An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer
-
in press
-
Gelman L, Fruchart J-C, Auwerx J. An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer. Cell Mol Life Sci 1999; 55: in press.
-
(1999)
Cell Mol Life Sci
, vol.55
-
-
Gelman, L.1
Fruchart, J.-C.2
Auwerx, J.3
-
8
-
-
0030835678
-
Organization, promoter analysis and expression of the human PPARy gene
-
Fajas L, Auboeuf D, Raspe E, Schoonjans K, Lefebvre AM, Saladin R, et al. Organization, promoter analysis and expression of the human PPARy gene. J Biol Chem 1997; 272:18779-18789.
-
(1997)
J Biol Chem
, vol.272
, pp. 18779-18789
-
-
Fajas, L.1
Auboeuf, D.2
Raspe, E.3
Schoonjans, K.4
Lefebvre, A.M.5
Saladin, R.6
-
9
-
-
0029102676
-
Structural organization of mouse peroxisome proliferator activated receptor y (mPPARy) gene: Alternative promoter use and different splicing yield two mPPARγ isoforms
-
Zhu Y, Qi C, Korenberg JR, Chen X-N, Noya D, Rao MS, et al. Structural organization of mouse peroxisome proliferator activated receptor y (mPPARy) gene: alternative promoter use and different splicing yield two mPPARγ isoforms. Proc Natl Acad Sci USA 1995; 92:7921-7925.
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, pp. 7921-7925
-
-
Zhu, Y.1
Qi, C.2
Korenberg, J.R.3
Chen, X.-N.4
Noya, D.5
Rao, M.S.6
-
10
-
-
0032582349
-
PPARγ3 mRNA: A distinct PPARγ mRNA subtype transcribed from an independent promoter
-
Fajas L, Fruchart JC, Auwerx J. PPARγ3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoter. FEBS Lett 1998; 438:55-60.
-
(1998)
FEBS Lett
, vol.438
, pp. 55-60
-
-
Fajas, L.1
Fruchart, J.C.2
Auwerx, J.3
-
11
-
-
0032560545
-
Expression of the peroxisome proliferator-activated receptor γ (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein
-
Ricote M, Huang J, Fajas L, Li A, Welch J, Najib J, et al. Expression of the peroxisome proliferator-activated receptor γ (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc Natl Acad Sci USA 1998; 95:7614-7619.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 7614-7619
-
-
Ricote, M.1
Huang, J.2
Fajas, L.3
Li, A.4
Welch, J.5
Najib, J.6
-
12
-
-
0032037738
-
PPARy activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes
-
Martin G, Schoonjans K, Staels B, Auwerx J. PPARy activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes. Atherosclerosis 1998; 137:75-80.
-
(1998)
Atherosclerosis
, vol.137
, pp. 75-80
-
-
Martin, G.1
Schoonjans, K.2
Staels, B.3
Auwerx, J.4
-
13
-
-
0027972524
-
Altered gene expression for tumor necrosis factor-α and its receptor during drug and dietary modulation of insulin resistance
-
Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJ, Hotamisligil GS, et al. Altered gene expression for tumor necrosis factor-α and its receptor during drug and dietary modulation of insulin resistance. Endocrinology 1994; 134:264-270.
-
(1994)
Endocrinology
, vol.134
, pp. 264-270
-
-
Hofmann, C.1
Lorenz, K.2
Braithwaite, S.S.3
Colca, J.R.4
Palazuk, B.J.5
Hotamisligil, G.S.6
-
14
-
-
0032520921
-
Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats
-
Okuno A, Tamemoto H, Tobe K, Ueki K, Mon Y, Iwamoto K, et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 1998; 101:1354-1361.
-
(1998)
J Clin Invest
, vol.101
, pp. 1354-1361
-
-
Okuno, A.1
Tamemoto, H.2
Tobe, K.3
Ueki, K.4
Mon, Y.5
Iwamoto, K.6
-
15
-
-
0029860791
-
Modulation of insulin activities by leptin
-
Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science 1996; 274:1185-1188.
-
(1996)
Science
, vol.274
, pp. 1185-1188
-
-
Cohen, B.1
Novick, D.2
Rubinstein, M.3
-
16
-
-
0040381066
-
Leptin impairs metabolic actions of insulin in isolated rat adipocytes
-
Muller G, Erti J, Gerl M, Preibisch G. Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J Biol Chem 1997; 272:10585-10593.
-
(1997)
J Biol Chem
, vol.272
, pp. 10585-10593
-
-
Muller, G.1
Erti, J.2
Gerl, M.3
Preibisch, G.4
-
17
-
-
0031567614
-
Leptin inhibits glycogen synthesis in isolated soleus muscle of obese (ob/ob) mice
-
Liu YL, Emilson V, Cawthorne MA. Leptin inhibits glycogen synthesis in isolated soleus muscle of obese (ob/ob) mice. FEBS Lett 1997; 411:351-355.
-
(1997)
FEBS Lett
, vol.411
, pp. 351-355
-
-
Liu, Y.L.1
Emilson, V.2
Cawthorne, M.A.3
-
18
-
-
0030811602
-
The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue availability in the rat
-
Oakes ND, Camilleri S, Furler SM, Chisholm DJ, Kraegen EW. The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue availability in the rat. Metabolism 1997; 46:935-942.
-
(1997)
Metabolism
, vol.46
, pp. 935-942
-
-
Oakes, N.D.1
Camilleri, S.2
Furler, S.M.3
Chisholm, D.J.4
Kraegen, E.W.5
-
19
-
-
50549202600
-
The glucose-fatty acid cycle: Its role in insulin sensitivity and metabolic disturbances of diabetes mellitus
-
Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose-fatty acid cycle: its role in insulin sensitivity and metabolic disturbances of diabetes mellitus. Lancet 1961; 1:785-789.
-
(1961)
Lancet
, vol.1
, pp. 785-789
-
-
Randle, P.J.1
Garland, P.B.2
Hales, C.N.3
Newsholme, E.A.4
-
20
-
-
0025945012
-
Insulin resistance: Mechanisms, syndromes, and implications
-
Moller DE, Flier JS. Insulin resistance: mechanisms, syndromes, and implications. N Engl J Med 1991; 325:938-948.
-
(1991)
N Engl J Med
, vol.325
, pp. 938-948
-
-
Moller, D.E.1
Flier, J.S.2
-
21
-
-
0032532152
-
Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: A model for congenital generalized lipodystrophy
-
Shimomura I, Hammer RE, Richardson JA, lkemoto S, Bashmakov Y, Goldstein JL, Brown MS. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: a model for congenital generalized lipodystrophy. Genes Dev 1998; 12:3182-3194.
-
(1998)
Genes Dev
, vol.12
, pp. 3182-3194
-
-
Shimomura, I.1
Hammer, R.E.2
Richardson, J.A.3
Lkemoto, S.4
Bashmakov, Y.5
Goldstein, J.L.6
Brown, M.S.7
-
22
-
-
0032532753
-
Life without fat: A transgenic mouse
-
Moitra J, Mason MM, Olive M, Krylov D, Gavrilova O, Marcus-Samuels B, et al. Life without fat: a transgenic mouse. Genes Dev 1998; 12:3168-3181.
-
(1998)
Genes Dev
, vol.12
, pp. 3168-3181
-
-
Moitra, J.1
Mason, M.M.2
Olive, M.3
Krylov, D.4
Gavrilova, O.5
Marcus-Samuels, B.6
-
23
-
-
0031441286
-
Troglitazone action is independent of adipose tissue
-
Burant CF, Sreenan S, Hirano K-I, Tai T-AC, Lohmiller J, Lukens J, et al. Troglitazone action is independent of adipose tissue. J Clin Invest 1997; 100:2900-2908.
-
(1997)
J Clin Invest
, vol.100
, pp. 2900-2908
-
-
Burant, C.F.1
Sreenan, S.2
Hirano, K.-I.3
Tai, T.-A.C.4
Lohmiller, J.5
Lukens, J.6
-
24
-
-
0032409985
-
Thiazolidinediones and insulin resistance: Peroxisome proliferator-activated receptor y activation stimulates expression of the CAP gene
-
c-Cbl-associated protein is the first PPARγ-sensitive gene identified that participates in insulin signaling and may play a role in thiazolidinedione-induced insulin sensitization
-
Ribon V, Johnson JH, Camp HS, Saltiel AR. Thiazolidinediones and insulin resistance: peroxisome proliferator-activated receptor y activation stimulates expression of the CAP gene. Proc Natl Acad Sci USA 1998; 95:14751-14756. c-Cbl-associated protein is the first PPARγ-sensitive gene identified that participates in insulin signaling and may play a role in thiazolidinedione-induced insulin sensitization.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 14751-14756
-
-
Ribon, V.1
Johnson, J.H.2
Camp, H.S.3
Saltiel, A.R.4
-
25
-
-
0032189782
-
Obesity associated with a mutation in a genetic regulator of adipocyte differentiation
-
Ristow M, Muller-Wieland D, Pfeiffer A, Krone W, Kahn CR. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N Engl J Med 1998; 339:953-959.
-
(1998)
N Engl J Med
, vol.339
, pp. 953-959
-
-
Ristow, M.1
Muller-Wieland, D.2
Pfeiffer, A.3
Krone, W.4
Kahn, C.R.5
-
26
-
-
0345164399
-
Molecular scanning of the human peroxisome proliferator activated receptor gamma gene in diabetic Caucasians: Identification of a Pro 12Ala PPAR gamma 2 missense mutation
-
Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yamall DP, et al Molecular scanning of the human peroxisome proliferator activated receptor gamma gene in diabetic Caucasians: identification of a Pro 12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun 1997; 241:270-274.
-
(1997)
Biochem Biophys Res Commun
, vol.241
, pp. 270-274
-
-
Yen, C.J.1
Beamer, B.A.2
Negri, C.3
Silver, K.4
Brown, K.A.5
Yamall, D.P.6
-
27
-
-
0031595923
-
A Pro 12 Ala substitution in the human peroxisome proliferator-activated receptor gamma2 is associated with decreased receptor activity, improved insulin sensitivity, and lowered body mass index
-
This article shows that a naturally occurring mutation of PPARγ2 is associated with decreased BMI, improved insulin sensitivity, and a lower transcriptional activity
-
Deeb S, Fajas L, Nemoto M, Laakso M, Fujimoto W, Auwerx J. A Pro 12 Ala substitution in the human peroxisome proliferator-activated receptor gamma2 is associated with decreased receptor activity, improved insulin sensitivity, and lowered body mass index. Nature Genet 1998; 20:284-287. This article shows that a naturally occurring mutation of PPARγ2 is associated with decreased BMI, improved insulin sensitivity, and a lower transcriptional activity.
-
(1998)
Nature Genet
, vol.20
, pp. 284-287
-
-
Deeb, S.1
Fajas, L.2
Nemoto, M.3
Laakso, M.4
Fujimoto, W.5
Auwerx, J.6
-
28
-
-
0031914386
-
Human peroxisome proliferator-activated receptor gamma 2: Genetic mapping, identification of a variant in the coding sequence, and exclusion as the gene responsible for lipoatrophic diabetes
-
Vigouroux C, Fajas L, Khallouf E, Meier M, Gyapay G, Auwerx J, et al. Human peroxisome proliferator-activated receptor gamma 2: genetic mapping, identification of a variant in the coding sequence, and exclusion as the gene responsible for lipoatrophic diabetes. Diabetes 1998; 47:490-492.
-
(1998)
Diabetes
, vol.47
, pp. 490-492
-
-
Vigouroux, C.1
Fajas, L.2
Khallouf, E.3
Meier, M.4
Gyapay, G.5
Auwerx, J.6
-
29
-
-
0031667127
-
Association of the Pro12Ala variant in peroxisome proliferator-activated receptor gamma2 gene with obesity in two Caucasian populations
-
Beamer BA, Yen CJ, Andersen RE, Muller D, Elahi D, Cheskin U, et al. Association of the Pro12Ala variant in peroxisome proliferator-activated receptor gamma2 gene with obesity in two Caucasian populations. Diabetes 1998; 47:1806-1808.
-
(1998)
Diabetes
, vol.47
, pp. 1806-1808
-
-
Beamer, B.A.1
Yen, C.J.2
Andersen, R.E.3
Muller, D.4
Elahi, D.5
Cheskin, U.6
-
30
-
-
0032500747
-
Effect of the Pro 12Ala variant of the human peroxisome proliferates activated receptor γ2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men
-
Mon Y, Kim-Motoyama H, Katakura T, Yasuda K, Kadowaki H, Beamer BB, et al. Effect of the Pro 12Ala variant of the human peroxisome proliferates activated receptor γ2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men. Biochem Biophys Res Commun 1998; 251:195-198.
-
(1998)
Biochem Biophys Res Commun
, vol.251
, pp. 195-198
-
-
Mon, Y.1
Kim-Motoyama, H.2
Katakura, T.3
Yasuda, K.4
Kadowaki, H.5
Beamer, B.B.6
-
31
-
-
0030877565
-
Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor γ (PPARγ)
-
Werman A, Hollenberg A, Solanes G, Bjorbaek C, Vidal-Puig A, Flier JS. Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor γ (PPARγ). J Biol Chem 1997; 272:20230-20235.
-
(1997)
J Biol Chem
, vol.272
, pp. 20230-20235
-
-
Werman, A.1
Hollenberg, A.2
Solanes, G.3
Bjorbaek, C.4
Vidal-Puig, A.5
Flier, J.S.6
-
32
-
-
0032569902
-
Interdomain communication regulating ligand binding by PPAR gamma
-
This article demonstrates that mutations or post-translational modifications of the A/B domain of PPARγ can modulate the ligand-dependent transcriptional activity of the E/F domain
-
Shao D, Rangwala SM, Bailey ST, Krakow SL, Reginato MJ, Lazar MA. Interdomain communication regulating ligand binding by PPAR gamma. Nature 1998; 396:377-380. This article demonstrates that mutations or post-translational modifications of the A/B domain of PPARγ can modulate the ligand-dependent transcriptional activity of the E/F domain.
-
(1998)
Nature
, vol.396
, pp. 377-380
-
-
Shao, D.1
Rangwala, S.M.2
Bailey, S.T.3
Krakow, S.L.4
Reginato, M.J.5
Lazar, M.A.6
-
33
-
-
0031793850
-
A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor α and γ. Effect of PPARα activation on normal lipid metabolism in liver of Zucker fatty rats
-
Murakami K, Tobe K, Ide T, Mochizuki T, Ohashi M, Akanuma Y, et al. A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor α and γ. Effect of PPARα activation on normal lipid metabolism in liver of Zucker fatty rats. Diabetes 1998; 47:1841-1847.
-
(1998)
Diabetes
, vol.47
, pp. 1841-1847
-
-
Murakami, K.1
Tobe, K.2
Ide, T.3
Mochizuki, T.4
Ohashi, M.5
Akanuma, Y.6
-
34
-
-
0032898052
-
Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidininedione derivative
-
Shibata T, Matsui K, Nagao K, Shinkai H, Yonemori F, Wakitani K. Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidininedione derivative. Eur J Pharmacol 1999; 364:211-219.
-
(1999)
Eur J Pharmacol
, vol.364
, pp. 211-219
-
-
Shibata, T.1
Matsui, K.2
Nagao, K.3
Shinkai, H.4
Yonemori, F.5
Wakitani, K.6
-
35
-
-
0030848473
-
Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct, but complementary mechanism relative to fibrates
-
Lefebvre A-M, Peinado-Onsurbe J, Leitersdorf I, Briggs MR, Paterniti JR, Fruchart J-C, et al. Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct, but complementary mechanism relative to fibrates. Arterioscler Thromb Vasc Biol 1997; 17:1756-1764.
-
(1997)
Arterioscler Thromb Vasc Biol
, vol.17
, pp. 1756-1764
-
-
Lefebvre, A.-M.1
Peinado-Onsurbe, J.2
Leitersdorf, I.3
Briggs, M.R.4
Paterniti, J.R.5
Fruchart, J.-C.6
-
36
-
-
0030062325
-
The structure activity relationship between peroxisome proliferator activated receptor γ agonism and the antihyperglycemic activity of thiazolidinediones
-
Willson TM, Cobb JE, Cowan DJ, Wiethe RW, Correa ID, Prakash SR, et al. The structure activity relationship between peroxisome proliferator activated receptor γ agonism and the antihyperglycemic activity of thiazolidinediones. J Med Chem 1996; 39:665-668.
-
(1996)
J Med Chem
, vol.39
, pp. 665-668
-
-
Willson, T.M.1
Cobb, J.E.2
Cowan, D.J.3
Wiethe, R.W.4
Correa, I.D.5
Prakash, S.R.6
-
37
-
-
0030831977
-
Peroxisome proliferator activated receptor y, CCAAT/ enhancer binding protein a, and cell cycle status regulate the commitment to adipocyte differentiation
-
Shao D, Lazar MA. Peroxisome proliferator activated receptor y, CCAAT/ enhancer binding protein a, and cell cycle status regulate the commitment to adipocyte differentiation. J Biol Chem 1997; 272:21473-21478.
-
(1997)
J Biol Chem
, vol.272
, pp. 21473-21478
-
-
Shao, D.1
Lazar, M.A.2
-
38
-
-
0030612740
-
PPARγ induces cell cycle withdrawal: Inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A
-
Altiok S, Xu M, Spiegelman B. PPARγ induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev 1997; 11:1987-1998.
-
(1997)
Genes Dev
, vol.11
, pp. 1987-1998
-
-
Altiok, S.1
Xu, M.2
Spiegelman, B.3
-
39
-
-
0033593231
-
Activation of peroxisome proliferator activated receptor γ bypasses the function of the retinoblastoma protein in adipocyte differentiation
-
The authors demonstrate that ligand induced activation of endogenous PPARγ is sufficient to initiate a transcriptional cascade resulting in induction of PPARγ2 and C/EBPα expression, withdrawal from the cell cycle, and terminal differentiation in the absence of a functional pRB
-
Hansen JB, Petersen RK, Larsen BM, Bartkova J, Alsner J, Kristiansen K. Activation of peroxisome proliferator activated receptor γ bypasses the function of the retinoblastoma protein in adipocyte differentiation. J Biol Chem 1999; 274:2386-2393. The authors demonstrate that ligand induced activation of endogenous PPARγ is sufficient to initiate a transcriptional cascade resulting in induction of PPARγ2 and C/EBPα expression, withdrawal from the cell cycle, and terminal differentiation in the absence of a functional pRB.
-
(1999)
J Biol Chem
, vol.274
, pp. 2386-2393
-
-
Hansen, J.B.1
Petersen, R.K.2
Larsen, B.M.3
Bartkova, J.4
Alsner, J.5
Kristiansen, K.6
-
40
-
-
12644265334
-
Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor
-
Tontonoz P, Singer S, Forman BM, Sarraf P, Fletcher JA, Brun RP, et al. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. Proc Natl Acad Sci USA 1997; 94:237-241.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 237-241
-
-
Tontonoz, P.1
Singer, S.2
Forman, B.M.3
Sarraf, P.4
Fletcher, J.A.5
Brun, R.P.6
-
41
-
-
0032555196
-
Ligands for peroxisome proliferator-activated receptor y and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells, in vitro and in BNX mice
-
This article points to the possible nontoxic and selective therapy for human breast cancers that a combined treatment with troglitazone and all-trans-retinoic acid may provide
-
Elstner E, Muller C, Koshizuka K, Williamson EA, Park D, Asou H, et al. Ligands for peroxisome proliferator-activated receptor y and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells, in vitro and in BNX mice. Proc Natl Acad Sci U S A 1998; 95:8806-8811. This article points to the possible nontoxic and selective therapy for human breast cancers that a combined treatment with troglitazone and all-trans-retinoic acid may provide.
-
(1998)
Proc Natl Acad Sci U S A
, vol.95
, pp. 8806-8811
-
-
Elstner, E.1
Muller, C.2
Koshizuka, K.3
Williamson, E.A.4
Park, D.5
Asou, H.6
-
42
-
-
0031993322
-
Terminal differentiation of human breast cancer through PPARγ
-
Mueller E, Sarraf P, Tontonoz P, Evans RM, Martin KJ, Zhang M, et al. Terminal differentiation of human breast cancer through PPARγ. Mol Cell 1998; 1:465-470.
-
(1998)
Mol Cell
, vol.1
, pp. 465-470
-
-
Mueller, E.1
Sarraf, P.2
Tontonoz, P.3
Evans, R.M.4
Martin, K.J.5
Zhang, M.6
-
43
-
-
0031595670
-
Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells
-
Brockman JA, Gupta RA, DuBois RN. Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells. Gastroenterology 1998; 115:1049-1055.
-
(1998)
Gastroenterology
, vol.115
, pp. 1049-1055
-
-
Brockman, J.A.1
Gupta, R.A.2
Dubois, R.N.3
-
44
-
-
0032145363
-
Ligand for peroxisome proliferator activated receptor γ (troglitazone) has potent antitumor effects against human prostate cancer both, in vitro and, in vivo
-
The authors suggest that troglitazone may be a useful therapeutic agent for the treatment of prostate cancer, especially in the setting of low disease burden
-
KubataT, Koshizuka K, Williamson IA, Asou H, Said JW, Holden S, et al. Ligand for peroxisome proliferator activated receptor γ (troglitazone) has potent antitumor effects against human prostate cancer both, in vitro and, in vivo. Cancer Res 1998; 58:3344-3352. The authors suggest that troglitazone may be a useful therapeutic agent for the treatment of prostate cancer, especially in the setting of low disease burden.
-
(1998)
Cancer Res
, vol.58
, pp. 3344-3352
-
-
KubataT1
Koshizuka, K.2
Williamson, I.A.3
Asou, H.4
Said, J.W.5
Holden, S.6
-
45
-
-
0031694577
-
Min/1 + mice
-
This paper shows that PPARγ is highly expressed in the colon and that mice carrying a mutated APC gene develop more and bigger tumours when treated with thiazolidinediones
-
Min/1 + mice. Nature Med 1998; 4:1053-1057. This paper shows that PPARγ is highly expressed in the colon and that mice carrying a mutated APC gene develop more and bigger tumours when treated with thiazolidinediones.
-
(1998)
Nature Med
, vol.4
, pp. 1053-1057
-
-
Lefebvre, A.1
Chen, I.2
Desreumaux, P.3
Najib, J.4
Fruchart, J.5
Geboes, K.6
-
46
-
-
0031667938
-
Activators of the nuclear receptor PPARγ enhance colon polyp formation
-
See Ref. [45••]
-
Saez E, Tontonoz P, Nelson MC, Alvarez JGA, Ming UT, Baird SM, et al. Activators of the nuclear receptor PPARγ enhance colon polyp formation. Nature Med 1998; 4:1058-1061. See Ref. [45••].
-
(1998)
Nature Med
, vol.4
, pp. 1058-1061
-
-
Saez, E.1
Tontonoz, P.2
Nelson, M.C.3
Alvarez, J.G.A.4
Ming, U.T.5
Baird, S.M.6
-
47
-
-
0030592517
-
Lessons from hereditary colorectal cancer
-
Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87:159-170.
-
(1996)
Cell
, vol.87
, pp. 159-170
-
-
Kinzler, K.W.1
Vogelstein, B.2
-
48
-
-
0029949369
-
Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa
-
Mansen A, Guardiola-Diaz H, Rafter J, Branting C, Gustafsson JA. Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa. Biochem Biophys Res Commun 1996; 222:844-851.
-
(1996)
Biochem Biophys Res Commun
, vol.222
, pp. 844-851
-
-
Mansen, A.1
Guardiola-Diaz, H.2
Rafter, J.3
Branting, C.4
Gustafsson, J.A.5
-
49
-
-
0028576901
-
Dietary factors and risk of colon cancer
-
Giovanucci E, Willet WC. Dietary factors and risk of colon cancer. Ann Med 1994; 26:443-452.
-
(1994)
Ann Med
, vol.26
, pp. 443-452
-
-
Giovanucci, E.1
Willet, W.C.2
-
50
-
-
0030903037
-
Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice
-
Wasan HS, Novelli M, Bee J, Bodmer WF. Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice. Proc Natl Acad Sci USA 1997; 94:3308-3313.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 3308-3313
-
-
Wasan, H.S.1
Novelli, M.2
Bee, J.3
Bodmer, W.F.4
-
51
-
-
0031671246
-
Differentiation and reversal of malignant changes in colon cancer through PPAR-/
-
Unlike References [45••] and [46••] this article suggests that treatment with thiazolidinediones inhibits the development of colon cancer in a xenograft model
-
Sarraf P, Mueller F, Jones D, King FJ, DeAngelo DJ, Partridge JB, et al. Differentiation and reversal of malignant changes in colon cancer through PPAR-/. Nature Med 1998; 4:1046-1052. Unlike References [45••] and [46••] this article suggests that treatment with thiazolidinediones inhibits the development of colon cancer in a xenograft model.
-
(1998)
Nature Med
, vol.4
, pp. 1046-1052
-
-
Sarraf, P.1
Mueller, F.2
Jones, D.3
King, F.J.4
DeAngelo, D.J.5
Partridge, J.B.6
-
52
-
-
0030047806
-
Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-α, -β, and -γ in the adult rat
-
Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, and -γ in the adult rat. Endocrinology 1995; 137:354-366.
-
(1995)
Endocrinology
, vol.137
, pp. 354-366
-
-
Braissant, O.1
Foufelle, F.2
Scotto, C.3
Dauca, M.4
Wahli, W.5
-
53
-
-
0030602866
-
The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation
-
Schoonjans K, Staels B, Auwerx J. The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1996; 1302:93-109.
-
(1996)
Biochim Biophys Acta
, vol.1302
, pp. 93-109
-
-
Schoonjans, K.1
Staels, B.2
Auwerx, J.3
-
54
-
-
0029994543
-
Role of the peroxisome proliferator activated receptor (PPAR) in mediating effects of fibrates and fatty acids on gene expression
-
Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferator activated receptor (PPAR) in mediating effects of fibrates and fatty acids on gene expression. J Lipid Res 1996; 37:907-925.
-
(1996)
J Lipid Res
, vol.37
, pp. 907-925
-
-
Schoonjans, K.1
Staels, B.2
Auwerx, J.3
-
55
-
-
0032489437
-
Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPAR alpha)
-
Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, et al. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPAR alpha). J Biol Chem 1998; 273:5678-5684.
-
(1998)
J Biol Chem
, vol.273
, pp. 5678-5684
-
-
Aoyama, T.1
Peters, J.M.2
Iritani, N.3
Nakajima, T.4
Furihata, K.5
Hashimoto, T.6
-
56
-
-
0030766476
-
Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice
-
Peters JM, Hennuyer N, Staels B, Fruchart JC, Fievet C, Gonzalez FJ, et al. Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice. J Biol Chem 1997; 272:27307-27312.
-
(1997)
J Biol Chem
, vol.272
, pp. 27307-27312
-
-
Peters, J.M.1
Hennuyer, N.2
Staels, B.3
Fruchart, J.C.4
Fievet, C.5
Gonzalez, F.J.6
-
57
-
-
0028997684
-
Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators
-
Lee SST, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, et al. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 1995; 15:3012-3022.
-
(1995)
Mol Cell Biol
, vol.15
, pp. 3012-3022
-
-
Lee, S.S.T.1
Pineau, T.2
Drago, J.3
Lee, E.J.4
Owens, J.W.5
Kroetz, D.L.6
-
58
-
-
0032491614
-
Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis
-
Costet P, Legendre C, More J, Edgar A, Galtier P, Pineau T. Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J Biol Chem 1998; 273:29577-29585.
-
(1998)
J Biol Chem
, vol.273
, pp. 29577-29585
-
-
Costet, P.1
Legendre, C.2
More, J.3
Edgar, A.4
Galtier, P.5
Pineau, T.6
-
59
-
-
0032530765
-
A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor alpha-deficient mice
-
In addition to a nice demonstration of the role of PPARα in lipid and glucose homeostasis, this article implicates oestrogen signalling pathways in the regulation of cardiac and hepatic lipid metabolism
-
Djouadi F, Weinheimer CJ, Saffitz JE, Pitchford C, BastinJ, Gonzalez FJ, et al. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor alpha-deficient mice. J Clin Invest 1998; 102:1083-1091. In addition to a nice demonstration of the role of PPARα in lipid and glucose homeostasis, this article implicates oestrogen signalling pathways in the regulation of cardiac and hepatic lipid metabolism.
-
(1998)
J Clin Invest
, vol.102
, pp. 1083-1091
-
-
Djouadi, F.1
Weinheimer, C.J.2
Saffitz, J.E.3
Pitchford, C.4
Bastin, J.5
Gonzalez, F.J.6
-
60
-
-
0032502704
-
Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome profiferator-activated receptor
-
This article shows that PPAR regulates the entry of fatty acids into the mitochondria, which is a crucial step in their metabolism, especially in tissues like heart skeletal muscle and brown adipose tissue in which fatty acids are a major source of energy. See also reference [61•]
-
Mascaro C, Acosta E, Ortiz JA, Marrero PF, Hegardt FG, Haro D. Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome profiferator-activated receptor. J Biol Chem 1998; 273:8560-8563. This article shows that PPAR regulates the entry of fatty acids into the mitochondria, which is a crucial step in their metabolism, especially in tissues like heart skeletal muscle and brown adipose tissue in which fatty acids are a major source of energy. See also reference [61•].
-
(1998)
J Biol Chem
, vol.273
, pp. 8560-8563
-
-
Mascaro, C.1
Acosta, E.2
Ortiz, J.A.3
Marrero, P.F.4
Hegardt, F.G.5
Haro, D.6
-
61
-
-
0032508696
-
Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha
-
This article demonstrates that long-chain fatty acids regulate the transcription of a gene encoding a pivotal enzyme in the mitochondrial fatty acid uptake pathway in cardiac myocytes and define a rote for PPARα in the control of myocardial lipid metabolism. See also reference [60•]
-
Brandt JM, Djouadi F, Kelly DP. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha. J Biol Chem 1998; 273:23786-23792. This article demonstrates that long-chain fatty acids regulate the transcription of a gene encoding a pivotal enzyme in the mitochondrial fatty acid uptake pathway in cardiac myocytes and define a rote for PPARα in the control of myocardial lipid metabolism. See also reference [60•].
-
(1998)
J Biol Chem
, vol.273
, pp. 23786-23792
-
-
Brandt, J.M.1
Djouadi, F.2
Kelly, D.P.3
-
62
-
-
0029661982
-
The PPARα-leukotriene B4 pathway to inflammation control
-
Devchand PR, Keller H, Peters JM, Vazquez M, Gonzalez FJ, Wahli W. The PPARα-leukotriene B4 pathway to inflammation control. Nature 1996; 384:39-43.
-
(1996)
Nature
, vol.384
, pp. 39-43
-
-
Devchand, P.R.1
Keller, H.2
Peters, J.M.3
Vazquez, M.4
Gonzalez, F.J.5
Wahli, W.6
-
63
-
-
0006132932
-
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
-
Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc Natl Acad Sci USA 1997; 94:4318-4323.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 4318-4323
-
-
Kliewer, S.A.1
Sundseth, S.S.2
Jones, S.A.3
Brown, P.J.4
Wisely, G.B.5
Koble, C.S.6
-
64
-
-
0033524415
-
Ligand selectivity of the peroxisome proliferator-activated receptor alpha
-
This article demonstrates the utility of an optical method in examining the ligand-selectivity of PPARs
-
Lin Q, Ruuska SE, Shaw NS, Dong D, Noy N. Ligand selectivity of the peroxisome proliferator-activated receptor alpha. Biochemistry 1999; 38:185-190. This article demonstrates the utility of an optical method in examining the ligand-selectivity of PPARs.
-
(1999)
Biochemistry
, vol.38
, pp. 185-190
-
-
Lin, Q.1
Ruuska, S.E.2
Shaw, N.S.3
Dong, D.4
Noy, N.5
-
65
-
-
0033613869
-
Phytanic acid activates the peroxisome proliferator-activated receptor alpha (PPAR alpha) in sterol carrier protein 2/ sterol carrier protein x-deficient mice
-
The authors suggest that phytanic acid can be considered as a new and genuine physiological ligand of murine PPARα
-
Ellinghaus P, Wolfrum C, Assmann G, Spener F, Seedorf U. Phytanic acid activates the peroxisome proliferator-activated receptor alpha (PPAR alpha) in sterol carrier protein 2/ sterol carrier protein x-deficient mice. J Biol Chem 1999; 274:2766-2772. The authors suggest that phytanic acid can be considered as a new and genuine physiological ligand of murine PPARα.
-
(1999)
J Biol Chem
, vol.274
, pp. 2766-2772
-
-
Ellinghaus, P.1
Wolfrum, C.2
Assmann, G.3
Spener, F.4
Seedorf, U.5
-
66
-
-
0029417191
-
Rat PPAR delta contains a CGG triplet repeat and is prominently expressed in the thalamic nuclei
-
Xing G, Zhang L, Zhang L, Heynen T, Yoshikawa T, Smith M, et al. Rat PPAR delta contains a CGG triplet repeat and is prominently expressed in the thalamic nuclei. Biochem Biophys Res Commun 1995; 217:1015-1025.
-
(1995)
Biochem Biophys Res Commun
, vol.217
, pp. 1015-1025
-
-
Xing, G.1
Zhang, L.2
Zhang, L.3
Heynen, T.4
Yoshikawa, T.5
Smith, M.6
-
67
-
-
0032030951
-
Member of the peroxisome proliferator-activated receptor family of transcription factors is differentially expressed by oligodendrocytes
-
Granneman J, Skoff R, Yang X. Member of the peroxisome proliferator-activated receptor family of transcription factors is differentially expressed by oligodendrocytes. J Neurosci Res 1998; 51:563-573.
-
(1998)
J Neurosci Res
, vol.51
, pp. 563-573
-
-
Granneman, J.1
Skoff, R.2
Yang, X.3
-
68
-
-
0030985318
-
Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by co-activator-dependent receptor ligand assay
-
Krey G, Braissant O, L'Horset F, Kalkhoven E, Peroud M, Parker MG, et al Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by co-activator-dependent receptor ligand assay. Mol Endocrinol 1997; 11:779-791.
-
(1997)
Mol Endocrinol
, vol.11
, pp. 779-791
-
-
Krey, G.1
Braissant, O.2
L'Horset, F.3
Kalkhoven, E.4
Peroud, M.5
Parker, M.G.6
-
69
-
-
0029955823
-
Identification of fatty acid methyl ester as naturally occurring transcriptional regulators of the members of the peroxisome proliferator-activated receptor family
-
Schmidt A, Vogel RL, Witherup KM, Rutledge SJ, Pitzenberger SM, Adam M, et al. Identification of fatty acid methyl ester as naturally occurring transcriptional regulators of the members of the peroxisome proliferator-activated receptor family. Lipids 1996; 31:1115-1124.
-
(1996)
Lipids
, vol.31
, pp. 1115-1124
-
-
Schmidt, A.1
Vogel, R.L.2
Witherup, K.M.3
Rutledge, S.J.4
Pitzenberger, S.M.5
Adam, M.6
-
70
-
-
0031458144
-
Structural requirements and cell-type specificity for ligand activation of peroxisome proliferator-activated receptors
-
Johnson TE, Holloway MK, Vogel R, Rutledge SJ, Perkins JJ, Rodan GA, et al. Structural requirements and cell-type specificity for ligand activation of peroxisome proliferator-activated receptors. J Steroid Biochem Mol Biol 1997; 63:1-8.
-
(1997)
J Steroid Biochem Mol Biol
, vol.63
, pp. 1-8
-
-
Johnson, T.E.1
Holloway, M.K.2
Vogel, R.3
Rutledge, S.J.4
Perkins, J.J.5
Rodan, G.A.6
-
71
-
-
13144283625
-
Identification of peroxisome proliferator-activated receptor ligands from a biased chemical library
-
Brown PJ, Smith-Oliver TA, Charifson PS, Tomkinson NC, Fivush AM, Sternbach DD, et al. Identification of peroxisome proliferator-activated receptor ligands from a biased chemical library. Chem Biol 1997; 4:909-918.
-
(1997)
Chem Biol
, vol.4
, pp. 909-918
-
-
Brown, P.J.1
Smith-Oliver, T.A.2
Charifson, P.S.3
Tomkinson, N.C.4
Fivush, A.M.5
Sternbach, D.D.6
-
72
-
-
0033525535
-
Novel peroxisome proliferator activated receptor (PPAR) γ and PPAR ligands produce distinct biological effects
-
The authors show that synthetic non-thiazolidinediones can serve as ligands of PPARγ and PPARδ, that among those new ligands the PPARγ agonists improve hyperglycaemia and hypertriglyceridaemia in vivo, but that the PPARδ activation does not appear to modulate glucose or triglyceride levels
-
Berger J, Leibowitz MD, DoebberTW, ElbrechtA, Zhang B, Zhou G, et al. Novel peroxisome proliferator activated receptor (PPAR) γ and PPAR ligands produce distinct biological effects. J Biol Chem 1999; 274:6718-6725. The authors show that synthetic non-thiazolidinediones can serve as ligands of PPARγ and PPARδ, that among those new ligands the PPARγ agonists improve hyperglycaemia and hypertriglyceridaemia in vivo, but that the PPARδ activation does not appear to modulate glucose or triglyceride levels.
-
(1999)
J Biol Chem
, vol.274
, pp. 6718-6725
-
-
Berger, J.1
Leibowitz, M.D.2
Doebber, T.W.3
Elbrecht, A.4
Zhang, B.5
Zhou, G.6
|